Status:
COMPLETED
The Effect of Walking on Fatigue After Chemotherapy in Patients 65 and Older
Lead Sponsor:
UNC Lineberger Comprehensive Cancer Center
Collaborating Sponsors:
Breast Cancer Research Foundation
Conditions:
Cancer
Geriatric
Eligibility:
All Genders
65+ years
Phase:
NA
Brief Summary
This study will look at the impact of a self-directed walking program on post-chemotherapy survivors experiencing fatigue. It is hypothesized that the walking program will help lessen fatigue.
Detailed Description
The investiagors propose to evaluate the impact of a home-based self-directed walking program on post-chemotherapy fatigue among 150 cancer survivors age 65 and older -- Senior Physical Activity after...
Eligibility Criteria
Inclusion
- Men and women age 65 years and older
- Histologically or cytologically confirmed cancer (hematologic or solid) at stage considered amenable to cure as assessed by the treating MD
- Within 6 weeks of end of chemotherapy (all participants must have had chemotherapy treatment)
- Any radiation received must also be completed prior to randomization (if radiation treatment follows adjuvant chemotherapy, then the patient must be recruited within 6 weeks of end of radiation)
- Maintenance hormonal therapy in women with breast cancer is allowed; see exclusion criteria regarding hormonal therapy in males with prostate cancer
- Moderate to severe fatigue (\>4 on BFI)
- Less than 120 minutes/week of physical activity
- English speaking
- Signed IRB approved written informed consent
- Approval from their treating physician to engage in moderate-intensity physical activity
- Patient-assessed ability to walk and engage in moderate physical activity
- Willing and able to meet all study requirements.
Exclusion
- Receiving hormonal therapy for prostate cancer
- Unable to walk or engage in moderate-intensity physical activity
- Have BFI≤3.
- Report more than 120 minutes/week of physical activity
Key Trial Info
Start Date :
June 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2017
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT02191982
Start Date
June 1 2014
End Date
August 1 2017
Last Update
September 12 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of North Carolina
Chapel Hill, North Carolina, United States, 27599